PlainPharmaWatch

CMS Open Payments · Tool

Clariance, Inc. vs Biotest AG

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Biotest AG has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,643, versus 882 for the other company. Its single largest recorded recipient represents 73.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Clariance, Inc.
HHI 882 · top recipient 16.1%
Ranked #1,075 of 1,838 companies by HHI
Biotest AG
HHI 5,643 · top recipient 73.5%
Ranked #286 of 1,838 companies by HHI

Payment Overview

Company A

Clariance, Inc.

Total Payments
$125.5K
% of Industry
0.0%
Transactions
206
Avg per Transaction
$609.20
Recipients
206
Avg per Recipient
$609.20
Payment Types
5
Top Payment Type
Consulting Fee
Company B

Biotest AG

Total Payments
$124.5K
% of Industry
0.0%
Transactions
10
Avg per Transaction
$12.5K
Recipients
5
Avg per Recipient
$24.9K
Payment Types
2
Top Payment Type
Compensation for Faculty or Speaker (Medical Education)

Highlighted values indicate the higher figure for each metric.

Total payments compared

Clariance, Inc. vs Biotest AG - total reported payments in CMS Open Payments PY2024

Clariance, Inc.$125.5KBiotest AG$124.5K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Clariance, Inc.

Consulting Fee $44.6K

35.5%

Travel and Lodging $42.6K

34.0%

Grant $20.0K

15.9%

Food and Beverage $11.8K

9.4%

Honoraria $6.5K

5.1%

Biotest AG

Compensation for Faculty or Speaker (Medical Education) $13.1K

88.9%

Consulting Fee $1.6K

11.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Clariance, Inc.

  1. 1

    RICHARD Burton MEYRAT

    $20,247.89 · 6 txns

  2. 2

    LANE SPERO

    $14,178.41 · 22 txns

  3. 3

    MUKUND GUNDANNA

    $12,996.86 · 16 txns

  4. 4

    BLAKE Wade BERMAN

    $12,667.30 · 10 txns

  5. 5

    JUSTIN DAZLEY

    $11,670.16 · 11 txns

Biotest AG

  1. 1

    LYNN MALEC

    $10,816.54 · 2 txns

  2. 2

    Stuart Adler

    $1,640.85 · 1 txns

  3. 3

    GUY YOUNG

    $1,213.33 · 1 txns

  4. 4

    BARBARA KONKLE

    $1,049.20 · 1 txns

Summary Comparison

Metric Clariance, Inc. Biotest AG
Total Payments $125.5K $124.5K
% of Industry Total 0.0% 0.0%
Transaction Count 206 10
Avg per Transaction $609.20 $12.5K
Recipient Count 206 5
Avg per Recipient $609.20 $24.9K
Payment Type Count 5 2
Top Payment Type Consulting Fee Compensation for Faculty or Speaker (Medical Education)

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.